Average Co-Inventor Count = 8.55
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (10 from 3,221 patents)
2. Cancer Research Technology Limited (6 from 262 patents)
3. F. Hoffmann-la Roche Ag (168 patents)
16 patents:
1. 12378249 - Isoquinoline compounds and uses thereof
2. 12297210 - Naphthyridine compounds and uses thereof
3. 12208088 - Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof
4. 11944606 - Azaindoles as inhibitors of HPK1
5. 11787792 - 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof
6. 11566003 - Isoquinolines as inhibitors of HPK1
7. 11034692 - Naphthyridines as inhibitors of HPK1
8. 10952995 - Azaindoles as inhibitors of HPK1
9. 10407424 - Naphthyridines as inhibitors of HPK1
10. 10259806 - 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof
11. 9951064 - Azaindazole compounds as inhibitors of T790M containing EGFR mutants
12. 9890152 - Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants
13. 9765059 - 5-(Pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use
14. 9663503 - 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof
15. 9403797 - 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use